Investing in neglected tropical diseases, successful partnerships

 

October 25, 2011

 

Organized by euSEND (European Solutions Enterprise on Neglected Diseases), a partnership of AMC, Department of Global Health, Amsterdam Institute for Global Health and Development (AIGHD),  Roland Berger Strategy Consultants, Royal Tropical Institute (KIT) and TI Pharma (TIP).

 

euSEND is a partnership between several public and private partners, where we match potential solutions to neglected tropical diseases (NTDs) with appropriate resources. We form and support public-private partnerships in R&D projects for drugs, diagnostics and solutions to NTDs.

 

This workshop was aimed at highlighting some of our projects and advocating the success of partnerships in global health and NTDs. The workshop was meant to motivate and stimulate partnerships and investments in NTDs.

 

View

- Program of the symposium
- Photos

 

Speakers and chairs

Christiaan Rebergen, Special Ambassador for the Millennium Development Goals and Public-Partnerships Ministry of Foreign Affairs

Hans Hogerzeil, former WHO Director for Essential Medicines and Pharmaceutical Policies

Henk Jan Out , Signature Initiative, MSD

Joep Lange, AMC Department of Global Health, AMC, UvA & AIGHD

Jorg Jansen, TI Pharma

Marcel Levi, Chairman, Executive Board of the AMC & Dean, Faculty of Medicine of the UvA

Michael Free, PATH

Michiel de Wilde, PharmAccess Foundation

Paul Klatser, KIT, Biomedical Research, AMC Department of Global Health, UvA & Athena Institute, VU University Amsterdam.

Ranald Sutherland, FIND  (cancelled)

Ted Bianco, Wellcome Trust.

Timothy Wells, Medicines, MMV

Trevor Jones, CBE & member of the International Scientific Review Committee, TI Pharma 

• archive >

• 6th interest workshop >

• hepatitis c >

• enterohaemorrhagic e. coli >

• when markets fail >

• malaria >